Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2026 Sep 8;17:1902375. doi: 10.3389/fphar.2026.1902375

Correction: Efficacy of combined sodium-glucose cotransporter 2 inhibitors and finerenone in chronic kidney disease: a systematic review and meta-analysis

Chen-Fu Wen 1,†, Min-Hsiang Chuang 2, Vin-Cent Wu 3,‡, Jui-Yi Chen 2,4,5,*
PMCID: PMC13595372  PMID: 42775199

Author Chen-Fu Wen was erroneously assigned as corresponding author. The correct corresponding author is Jui-Yi Chen.

The original version of this article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES